Silex Systems Limited (SILXF) Fair Value & Analysis
Technology · US · Market cap $1.1B
Fair value as of: Jun 24, 2026
From 8 valuation models · updated 22 days ago
Fair value updated Jun 24, 2026, revised from $0.2400 to $0.6800 (+183.3%) since Jun 23, 2026. Share price −17.7% over the past month.
Price vs Fair Value (12 months)
12‑month range $2.40 – $7.20 · fair‑value band $0.5100 – $0.8400 · the $3.25 price screens above the $0.6800 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Silex Systems Limited (SILXF) currently trades at $3.25, while our model-based Fair Value estimate is $0.6800, implying the stock looks roughly 79.1% overvalued today. We read business quality at 39/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Trailing-twelve-month revenue stands at $18.9M. Revenue grew 65.8% year over year. It earns a return on equity of -25.6%. Fundamentals as of Jun 24, 2026
Our scenario range runs from $0.5100 (bear case) to $0.8400 (bull case); at $3.25, the current price sits above that range. The share trades about 55% below its 52-week high and 41% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -53% fair-value upside, at -79%, SILXF screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. It operates through three segments: Silex Systems, Translucent, and Silex USA. The company also sells its cREO technology. In addition, it develops its laser-based enrichment technology for use in various applications comprising uranium production and enrichment for nuclear power; silicon enrichment for silicon quantum computing; and medical isotope enrichment for new cancer therapies. Silex Systems Limited was incorporated in 1987 and is based in Lucas Heights, Australia.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Silex Systems Limited reported revenue of $6.8M in FY2025 versus $1.9M in FY2021, a compound +37.1%/yr. Reported net income was −$42.6M in FY2025.
Is SILXF fairly valued? → Check now
Similar stocks
10 more Semiconductors stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| NVIDIA Corporation NVDA | CHF 166.13 | CHF 77.51 | -53% |
| Taiwan Semiconductor Manufacturing Company TSMC34 | R$267.00 | R$181.37 | -32% |
| Broadcom Inc AVGO | $418.91 | $116.61 | -72% |
| Micron Technology, Inc ZMIC | C$52.57 | C$7.68 | -85% |
| SK hynix Inc 000660 | 1,000,000 KRW | 1,109,311 KRW | +11% |
| Advanced Micro Devices, Inc 1AMD | €464.70 | €56.33 | -88% |
| Intel Corporation INTC | C$68.40 | C$39.93 | -42% |
| Texas Instruments Incorporated TXN | $282.01 | $71.71 | -75% |
| Marvell Technology, Inc MRVL | $307.86 | $36.61 | -88% |
| 1YD 1YD | €341.70 | €599.74 | +76% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Silex Systems Limited (SILXF) undervalued?
What is the fair value of SILXF?
What is the quality score of SILXF?
What is the revenue of Silex Systems Limited (SILXF)?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Silex Systems Limited analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.